黄斑消肿方联合雷珠单抗治疗气滞血瘀型视网膜分支静脉阻塞黄斑水肿的临床疗效
朱成义， 李冬， 伊琼， 韦企平 - 北京中医药, 2023 - bjtcm.net
… The 10-year incidence and risk factors of retinal vein occlusion: the Beijing eye study[J].…
secondary to retinal vein occlusion in Chinese patients:randomized,sham-controlled,multicenter …
secondary to retinal vein occlusion in Chinese patients:randomized,sham-controlled,multicenter …
[PDF][PDF] 玻璃体腔注射Ranibizumab 联合视网膜光凝治疗视网膜分支静脉阻塞继发黄斑水肿
B Liu, YX Yang, X Liu, WL Li, ZZ Mo - core.ac.uk
… secondary to branch retinal vein occlusion (BRVO). 誗METHODS: Forty-two confirmed cases
(42 … The 10-year incidence and risk factors of retinal vein occlusion:the Beijing eye study. …
(42 … The 10-year incidence and risk factors of retinal vein occlusion:the Beijing eye study. …
视神经脊髓炎生物标记物: 新兴研究趋势的可视化分析
X Li, J Zhang, S Zhang, S Shi, Y Lu, Y Leng… - 中国神经再生研究(英文 …, 2024 - sjzsyj.com.cn
… The primary endpoint of this study is to identify risk factors for 10-year disability progression
by integrating peripheral blood biomarkers, retinal structure, visual function, and historical …
by integrating peripheral blood biomarkers, retinal structure, visual function, and historical …